News and Announcements

$2.6B Market Breakthrough in Cardiac Technology | EBR Systems
- Published January 29, 2025 1:02AM UTC
- Publisher Maan Perez
- Categories Executive Interviews
Join the conversation with Andrew Shute, SVP of EBR Systems, as we explore the innovative VICRD system, a leadless device poised to transform cardiac resynchronization therapy. Discover its advantages over traditional therapies, a $3.6 billion market potential, and promising clinical outcomes. Learn about EBR Systems’ U.S. expansion strategy, their pioneering rechargeable battery technology, and key milestones ahead. This episode delves into an innovation that not only advances medical technology but also offers new hope for heart failure patients.
Executive Interviews
Backed By Leading Investment Groups and Family Offices



